Acino ac­quires South Africa’s Litha Health­care

BioSpectrum (Asia) - - World News -

Swiss phar­ma­ceu­ti­cal com­pany, Acino, has bought Joburg-based Litha Health­care, giv­ing the for­mer im­me­di­ate ac­cess to the South African mar­ket. Litha’s ex­ist­ing prod­uct port­fo­lio com­prises nearly 100 mol­e­cules fo­cus­ing on pri­mary care, largely through orig­i­na­tor prod­ucts, and spe­cialty care, partly through generic prod­ucts.

Through its forensic busi­ness, it pro­vides the South African po­lice with DNA ev­i­dence col­lec­tion and crime scene kits. Litha also has a strong pipe­line of 124 prod­ucts that are ex­pected to be launched within the next five years.

In ad­di­tion to this pipe­line, Acino plans to com­ple­ment the port­fo­lio by launch­ing a se­lec­tion of their ex­ist­ing prod­ucts in South Africa in the up­com­ing years. Litha has a strong po­si­tion in the mar­ket and a solid rep­u­ta­tion in sev­eral ther­a­peu­tic ar­eas that are strate­gic for Acino.

Litha Health­care fore­sees that the syn­er­gies be­tween the or­gan­i­sa­tions will fur­ther sup­port the com­pany’s vi­sion of be­ing one of the top 10 pharma com­pa­nies in South Africa.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.